Analysis of Patients with Epithelial Ovarian Cancer or Fallopian Tube Carcinoma Retreated with Cisplatin after the Development of a Carboplatin Allergy

Author： Dizon D.S.   Sabbatini P.J.   Aghajanian C.   Hensley M.L.   Spriggs D.R.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.84, Iss.3, 2002-03, pp. : 378-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

By Campos Susana  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 105-107

Informa Healthcare

Access to resources Recommend Favorite

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

By Meerpohl H.G.   Sauerbrei W.   Kuhnle H.   Schumacher M.   Pfleiderer A.   German Ovarian Cancer Study Group GOCA  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 75-84

Elsevier

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 35-38

Spandidos Publications

Access to resources Recommend Favorite

A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer

By Mori Taisuke   Hosokawa Kenichi   Kinoshita Yoshiyuki   Watanabe Ai   Yamaguchi Takeshi   Kuroboshi Haruo   Kato Yoshiko   Yasuda Jinsuke   Fujita Hiroyuki   Nakata Yoshinori   Honjo Hideo  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 205-211

Springer Publishing Company

Access to resources Recommend Favorite

Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I-II Study

By Lorusso V.   Leone B.   Di Vagno G.   Manzione L.   Palmeri S.   Vallejo C.   Machiavelli M.   Nacci G.   Bilancia D.   Leonardi V.   Catino A.   Gargano G.   Loverro G.   Selvaggi L.   De Lena M.  

Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite